Duchenne muscular dystrophy patients show reduced erythrocyte (Na+, K+)ATPase activity. A plasma factor in these patients alters enzyme response to ouabain, suggesting a potential biomarker.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: